Serving Overlooked PatientsSM
We develop dose-form innovations of established medicines for patients who have unmet needs.
Azurity specializes in providing innovative, high-quality medicines that serve overlooked patients.
We supply a large number of products to treat a wide range of medical conditions. These include cardiovascular, central nervous system, endocrine, gastro-intestinal, anti-infective and oncology medicines. Many of our medicines are dose-form innovations for patients with needs that are not met by other available products. Our medicines have benefited millions of people.
PRODUCT ANNOUNCEMENT
Click for Full Prescribing Information, including Indications and Safety Information.
PRODUCT ANNOUNCEMENT
Click for Full Prescribing Information, including Indications and Safety Information.
PRODUCT ANNOUNCEMENT
Click for Full Prescribing Information, including Indications and Safety Information.
PRODUCT ANNOUNCEMENT
Click for Full Prescribing Information, including Indications and Safety Information.
OUR PRODUCTS
Azurity offers an ever expanding portfolio of products targeting key therapeutic areas.
News & Events
AZURITY PHARMACEUTICALS, INC. ANNOUNCES AVAILABILITY OF
AZMIRO™ (testosterone cypionate) injection for intramuscular use, CIII
MEDIA ALERT: WOBURN, Mass. December 11, 2024 – Azurity Pharmaceuticals announced today the availability of Azmiro™, the first and only FDA-approved prefilled testosterone cypionate injection. Azmiro is an androgen indicated for testosterone replacement therapy in males for conditions associated with a deficiency…
AZURITY PHARMACEUTICALS, INC. ANNOUNCES FDA APPROVAL OF
DANZITEN™ (nilotinib) tablets, THE FIRST AND ONLY NILOTINIB WITH NO MEALTIME RESTRICTIONS
MEDIA ALERT: WOBURN, Mass. Nov 14, 2024 – Azurity Pharmaceuticals announced today that the U.S. Food and Drug Administration (FDA) has approved Danziten™, the first and only nilotinib with no mealtime restrictions indicated for adult patients with newly diagnosed Philadelphia chromosome positive…
